+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Colorectal Cancer Screening Market Analysis & Forecast to 2024-2034

  • PDF Icon

    Report

  • 200 Pages
  • January 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5923125
The global colorectal cancer screening market size was estimated to be USD 14.75 billion in 2023 and is expected to reach at USD 26.53 billion by 2034 with a CAGR of 5.48% during the forecast period 2024-2034. Rising emphasis on developing & commercializing technologically advanced products for efficient screening, increasing incidence of colorectal cancer, growing awareness regarding the importance of early testing & treatment of the disease, surge in approvals for these screening tests, the implementation of government programs to control its side effects, and a growing focus among the major companies on the introduction of cutting-edge and novel items are some of the key factors boosting the market growth.

A growing focus among the major companies on the introduction of cutting-edge and novel items is predicted to boost the market growth during the forecast period. Colorectal Cancer (CRC) is a type of cancer that develops in the colon or rectum, part of the digestive tract, as cancerous cells begin to grow. Often referred to as bowel cancer, CRC screening involves identifying the disease in individuals who show no symptoms but are at a high risk of developing the condition, typically aged 45 and above. The growing incidence of CRC underscores the importance of screening for early diagnosis and treatment. For instance, in May 2022, Guardant Health has introduced Shield, a blood-based test designed for the early detection of colorectal cancer in adults aged 45 and older. This test, which involves a blood draw, is intended for individuals who are not in compliance with recommended screening guidelines, display no symptoms, and are at an average risk for colorectal cancer.

By type, colonoscopy was the highest revenue-grossing segment in the global colorectal cancer screening market in 2023 owing to the procedure exhibits a high level of accuracy, coinciding with a rising incidence of colorectal cancer, ongoing technological advancements, and an increasing number of product launches. For instance, in August 2022, India Medtronic Private Limited has unveiled a groundbreaking computer-aided polyp detection system, the GI Genius intelligent endoscopy module, powered by artificial intelligence (AI). This innovative solution relies on deep learning algorithms and real-time data to empower physicians in the detection and treatment of colorectal cancer by providing enhanced visualization during colonoscopy. Additionally, stool-based is predicted to grow at fastest CAGR during the forecast period owing to the increasing government initiatives for colorectal cancer screening, along with the prompt results achieved through stool-based tests, rising adoption of FIT screening tests due to their simplicity & higher positivity rates compared to other stool-based tests.

By end-user, hospitals & clinics was the highest revenue-grossing segment in the global colorectal cancer screening market in 2023 owing to the substantial number of hospitals, rising volume of colorectal cancer (CRC) screening procedures conducted within hospital settings, and increasing regulatory approvals. For instance, in December 2022, Therascreen KRAS RGQ PCR Kit for colorectal cancer screening, manufactured by QIAGEN Manchester Ltd., was authorized by the FDA. Additionally, diagnostics imaging centers is predicted to grow at fastest CAGR during the forecast period owing to the growing trend in colorectal cancer screening through colonoscopies, accompanied by an increasing number of diagnostic centers that offer and conduct colonoscopy procedures.

North America region is anticipated for the highest revenue share during the forecast period owing to the increasing adoption of technologically advanced & high-cost tests, growing awareness of colorectal cancer, rising demand for screening procedures such as stool-based testing, the presence of government programs further contributes to this trend, and surge in research & development activities. For instance, in December 2022, Guardant Health, Inc., a company based in the United States, has announced positive results from the ECLIPSE study (Evaluation of ctDNA LUNAR Assay In an Average Patient Screening Episode). This study, which involved over 20,000 patients, was conducted to evaluate the performance of Guardant Health's blood test in detecting colorectal cancer (CRC) in average-risk adults. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising trend in enhancing & improving healthcare facilities, increasing incidence of colorectal cancer, individuals are becoming more conscious of achieving better treatment outcomes, surge in awareness regarding the disease, and growing collaborations within market players for the launch of new products. For instance, in May 2022, Prenetics and New Horizon Health established their strategic alliance to introduce ColoClear by Circle in China.

Segmentation: Colorectal Cancer Screening Market Report 2023 - 2034

Colorectal Cancer Screening Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)

  • Stool-Based
  • Fecal Occult Blood Test (FOBT)
  • Fecal Immunochemical Test (FIT)
  • Stool-DNA Test
  • Colonoscopy
  • Others

Colorectal Cancer Screening Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)

  • Clinical Laboratories
  • Hospitals & Clinics
  • Diagnostic Imaging Centers
  • Others

Colorectal Cancer Screening Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Colorectal Cancer Screening Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Colorectal Cancer Screening Market: Type Estimates & Trend Analysis
7.1. Type Segment Opportunity Analysis
7.2. Stool-Based
7.2.1. Stool-Based Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Fecal Occult Blood Test (FOBT)
7.3.1. Fecal Occult Blood Test (FOBT) Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Fecal Immunochemical Test (FIT)
7.4.1. Fecal Immunochemical Test (FIT) Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5. Stool-DNA Test
7.5.1. Stool-DNA Test Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.6. Colonoscopy
7.6.1. Colonoscopy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.7. Others
7.7.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Colorectal Cancer Screening Market: End-user Estimates & Trend Analysis
8.1. End-user Segment Opportunity Analysis
8.2. Clinical Laboratories
8.2.1. Clinical Laboratories Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Hospitals & Clinics
8.3.1. Hospitals & Clinics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Diagnostic Imaging Centers
8.4.1. Diagnostic Imaging Centers Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.5. Others
8.5.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Regional Market Analysis
9.1. Regional Market Opportunity Analysis
10. North America Colorectal Cancer Screening Market
10.1. North America Colorectal Cancer Screening Market
10.1.1. North America Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.1.2. North America Colorectal Cancer Screening Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
10.1.3. North America Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
10.1.4. North America Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
10.2. U.S. Global Colorectal Cancer Screening Market
10.2.1. U.S. Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.2.2. U.S. Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
10.2.3. U.S. Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
10.3. Canada Global Colorectal Cancer Screening Market
10.3.1. Canada Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.3.2. Canada Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
10.3.3. Canada Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11. Europe Global Colorectal Cancer Screening Market
11.1. Europe Global Colorectal Cancer Screening Market
11.1.1. Europe Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. Europe Colorectal Cancer Screening Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. Europe Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
11.1.4. Europe Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.2. Germany Global Colorectal Cancer Screening Market
11.2.1. Germany Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. Germany Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
11.2.3. Germany Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.3. UK Global Colorectal Cancer Screening Market
11.3.1. UK Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. UK Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
11.3.3. UK Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.4. France Global Colorectal Cancer Screening Market
11.4.1. France Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.4.2. France Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
11.4.3. France Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.5. Spain Global Colorectal Cancer Screening Market
11.5.1. Spain Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.5.2. Spain Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
11.5.3. Spain Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.6. Italy Global Colorectal Cancer Screening Market
11.6.1. Italy Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.6.2. Italy Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
11.6.3. Italy Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.7. Rest of Europe Global Colorectal Cancer Screening Market
11.7.1. Rest of Europe Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.7.2. Rest of Europe Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
11.7.3. Rest of Europe Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12. Asia Pacific Global Colorectal Cancer Screening Market
12.1. Asia Pacific Global Colorectal Cancer Screening Market
12.1.1. Asia Pacific Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Asia Pacific Colorectal Cancer Screening Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Asia Pacific Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.1.4. Asia Pacific Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.2. Japan Global Colorectal Cancer Screening Market
12.2.1. Japan Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Japan Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.2.3. Japan Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.3. China Global Colorectal Cancer Screening Market
12.3.1. China Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. China Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.3.3. China Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.4. India Global Colorectal Cancer Screening Market
12.4.1. India Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. India Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.4.3. India Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.5. South Korea Global Colorectal Cancer Screening Market
12.5.1. South Korea Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. South Korea Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.5.3. South Korea Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.6. Australia Global Colorectal Cancer Screening Market
12.6.1. Australia Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Australia Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.6.3. Australia Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.7. Rest of Asia Pacific Global Colorectal Cancer Screening Market
12.7.1. Rest of Asia Pacific Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Asia Pacific Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Asia Pacific Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13. Latin America Global Colorectal Cancer Screening Market
13.1. Latin America Global Colorectal Cancer Screening Market
13.1.1. Latin America Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Latin America Colorectal Cancer Screening Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Latin America Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.1.4. Latin America Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.2. Brazil Global Colorectal Cancer Screening Market
13.2.1. Brazil Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Brazil Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.2.3. Brazil Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.3. Mexico Global Colorectal Cancer Screening Market
13.3.1. Mexico Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. Mexico Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.3.3. Mexico Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.4. Argentina Global Colorectal Cancer Screening Market
13.4.1. Argentina Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. Argentina Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.4.3. Argentina Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.5. Rest of Latin America Global Colorectal Cancer Screening Market
13.5.1. Rest of Latin America Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. Rest of Latin America Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.5.3. Rest of Latin America Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14. MEA Global Colorectal Cancer Screening Market
14.1. MEA Global Colorectal Cancer Screening Market
14.1.1. MEA Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. MEA Colorectal Cancer Screening Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. MEA Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.1.4. MEA Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.2. GCC Global Colorectal Cancer Screening Market
14.2.1. GCC Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. GCC Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.2.3. GCC Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.3. South Africa Global Colorectal Cancer Screening Market
14.3.1. South Africa Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. South Africa Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.3.3. South Africa Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.4. Rest of MEA Global Colorectal Cancer Screening Market
14.4.1. Rest of MEA Colorectal Cancer Screening Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Rest of MEA Colorectal Cancer Screening Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.4.3. Rest of MEA Colorectal Cancer Screening Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15. Competitor Analysis
15.1. Company Market Share Analysis, 2023
15.2. Major Recent Developments
16. Company Profiles
16.1. bioMérieux, Inc.
16.2. NOVIGENIX SA
16.3. KARL STORZ SE & Co. KG
16.4. Olympus Corporation
16.5. Exact Sciences Corporation
16.6. Epigenomics AG
16.7. FUJIFILM Holdings America Corporation
16.8. Clinical Genomics Technologies Pty Ltd.
16.9. EIKEN CHEMICAL CO., LTD.
16.10. Other Prominent Players
17. Conclusion18. Recommendations

Companies Mentioned

  • bioMérieux Inc.
  • NOVIGENIX SA
  • KARL STORZ SE & Co. KG
  • Olympus Corporation
  • Exact Sciences Corporation
  • Epigenomics AG
  • FUJIFILM Holdings America Corporation
  • Clinical Genomics Technologies Pty Ltd.
  • EIKEN CHEMICAL CO. Ltd.

Table Information